François Laliberté

24PUBLICATIONS
40CO-AUTHORS
PharmacogenomicsCharacterisation of biological macromoleculesCell physiologySystems physiologyEmergency medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Jan 19, 2026
FF/UMEC/VI and BUD/GLY/FORM in Patients with COPD Stepping Up from Dual Therapy Stratified by Exacerbations and Prior Dual Therapy: A Subgroup Analysis of a Comparative Effectiveness Study.

Jadwiga A Wedzicha, Stephen G Noorduyn, Valentina Di Boscio

|Nov 30, 2025
Economic impact of using cariprazine as the first versus subsequent adjunctive therapy for Medicaid beneficiaries with major depressive disorder.

Prakash S Masand, Anita H Clayton, Mousam Parikh

|Sep 04, 2025
Real-World Disability Outcomes Among Patients Treated with Cariprazine vs Other Atypical Antipsychotics as Adjunctive Treatment for Major Depressive Disorder.

Prakash S Masand, Mousam Parikh, Jamie T Ta

|Jul 06, 2025
Comparative Effectiveness of FF/UMEC/VI and BUD/GLY/FORM in Patients with COPD Stepping Up From Dual Therapy.

Jadwiga A Wedzicha, Stephen G Noorduyn, Valentina Di Boscio

|Feb 19, 2025
The real-world impact of cariprazine on short- and long-term disability outcomes among commercially insured patients in the United States.

Prakash S Masand, Mousam Parikh, Jamie Ta

|Jan 22, 2025
Healthcare resource utilization and costs of using cariprazine as the first versus subsequent adjunctive therapy for major depressive disorder.

Prakash S Masand, Anita H Clayton, Mousam Parikh

Pageof 4

Frequent Collaborators

10 joint publications

Dominique Lejeune

10 joint publications

Guillaume Germain

5 joint publications

Rosirene Paczkowski

5 joint publications

Stephen G Noorduyn